Computational exploration and anti-mycobacterial activity of potential inhibitors of Mycobacterium tuberculosis acetyl coenzyme A carboxylase as anti-tubercular agents

References

• M. Martini, G. Besozzi, and I. Barberis, The never-ending story of the fight against tuberculosis: From Koch’s bacillus to global control programs, J. Prev. Med. Hyg. 59 (2018), pp. E241–E247. doi:10.15167/2421-4248/jpmh2018.59.3.1051.
   PubMedGoogle Scholar
• M. Marimani, A. Ahmad, and A. Duse, The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection, Tuberculosis (Edinb) 113 (2018), pp. 200–214. doi:10.1016/j.tube.2018.10.009.
   PubMed Web of Science ®Google Scholar
• S. Ravimohan, H. Kornfeld, D. Weissman, and G.P. Bisson, Tuberculosis and lung damage: From epidemiology to pathophysiology, Eur. Respir. Rev. 27 (2018), pp. 170077. doi:10.1183/16000617.0077-2017.
   PubMed Web of Science ®Google Scholar
• G.K. Sandhu, Tuberculosis: Current situation, challenges and overview of its control programs in India, J. Glob. Infect. Dis. 3 (2011), pp. 143–150. doi:10.4103/0974-777X.81691.
   PubMedGoogle Scholar
• Y.J. Ryu, Diagnosis of pulmonary tuberculosis: Recent advances and diagnostic algorithms, Tuberc. Respir. Dis. 78 (2015), pp. 64–71. doi:10.4046/trd.2015.78.2.64.
   PubMed Web of Science ®Google Scholar
• D.N. Rose, C.B. Schechter, and J.J. Adler, Interpretation of the tuberculin skin test, J. Gen. Intern. Med. 10 (1995), pp. 635–642. doi:10.1007/BF02602749.
   PubMed Web of Science ®Google Scholar
• M.F. Wipperman, D.W. Fitzgerald, M.A.J. Juste, Y. Taur, S. Namasivayam, A. Sher, J.M. Bean, V. Bucci, and M.S. Glickman, Antibiotic treatment for tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed, Sci. Rep. 7 (2017), pp. 1–11. doi:10.1038/s41598-017-10346-6.
   PubMed Web of Science ®Google Scholar
• V. Lohrasbi, M. Talebi, A.Z. Bialvaei, L. Fattorini, M. Drancourt, M. Heidary, and D. Darban-Sarokhalil, Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance, Tuberculosis (Edinb) 109 (2018), pp. 17–27. doi:10.1016/j.tube.2017.12.002.
   PubMed Web of Science ®Google Scholar
• R. Singh, S.P. Dwivedi, U.S. Gaharwar, R. Meena, P. Rajamani, and T. Prasad, Recent updates on drug resistance in Mycobacterium tuberculosis, J. Appl. Microbiol. 128 (2020), pp. 1547–1567. doi:10.1111/jam.14478.
   PubMed Web of Science ®Google Scholar
• D.C. Quenelle, G.A. Winchester, J.K. Staas, E.L. Barrow, and W.W. Barrow, Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid, Antimicrob. Agents Chemother. 45 (2001), pp. 1637–1644. doi:10.1128/AAC.45.6.1637-1644.2001.
   PubMed Web of Science ®Google Scholar
• T. Maitre, A. Aubry, V. Jarlier, J. Robert, and N. Veziris, Multidrug and extensively drug-resistant tuberculosis, Med. Mal. Infect. 47 (2017), pp. 3–10. doi:10.1016/j.medmal.2016.07.006.
   PubMed Web of Science ®Google Scholar
• M.L. Bastos, H. Hussain, K. Weyer, L. Garcia-Garcia, V. Leimane, C.C. Leung, M. Narita, J.M. Penã, A. Ponce-de-Leon, and K.J. Seung, Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first-and second-line drugs: An individual patient data meta-analysis, Clin. Infect. Dis. 59 (2014), pp. 1364–1374. doi:10.1093/cid/ciu619.
   PubMed Web of Science ®Google Scholar
• H. Tomioka, Prospects for development of new antimycobacterial drugs, J. Infect. Chemother. 6 (2000), pp. 8–20. doi:10.1007/s101560050043.
   PubMedGoogle Scholar
• C.D. Wells, J.P. Cegielski, L.J. Nelson, K.F. Laserson, T.H. Holtz, A. Finlay, K.G. Castro, and K. Weyer, HIV infection and multidrug-resistant tuberculosis—the perfect storm, J. Glob. Infect. Dis. 196 (2007), pp. S86–S107. doi:10.1086/518665.
   Google Scholar
• J.R. Andrews, N. Sarita Shah, N. Gandhi, T. Moll, and G. Friedland, Multidrug-resistant and extensively drug-resistant tuberculosis: Implications for the HIV epidemic and antiretroviral therapy rollout in South Africa, J. Glob. Infect. Dis. 196 (2007), pp. S482–S490. doi:10.1086/521121.
   Google Scholar
• R.J. Kinsella, D.A. Fitzpatrick, C.J. Creevey, and J.O. McInerney, Fatty acid biosynthesis in Mycobacterium tuberculosis: Lateral gene transfer, adaptive evolution, and gene duplication, Proc. Natl. Acad. Sci. U. S. A. 100 (2003), pp. 10320–10325. doi:10.1073/pnas.1737230100.
   PubMed Web of Science ®Google Scholar
• S. Jamet, Y. Quentin, C. Coudray, P. Texier, F. Laval, M. Daffé, G. Fichant, and K. Cam, Evolution of mycolic acid biosynthesis genes and their regulation during starvation in Mycobacterium tuberculosis, J. Bacteriol. 197 (2015), pp. 3797–3811. doi:10.1128/JB.00433-15.
   PubMed Web of Science ®Google Scholar
• M.C. Reddy, A. Breda, J.B. Bruning, M. Sherekar, S. Valluru, C. Thurman, H. Ehrenfeld, and J.C. Sacchettini, Structure, activity, and inhibition of the carboxyltransferase β-subunit of acetyl coenzyme A carboxylase (AccD6) from Mycobacterium tuberculosis, Antimicrob. Agents Chemother. 58 (2014), pp. 6122–6132. doi:10.1128/AAC.02574-13.
   PubMed Web of Science ®Google Scholar
• LigPrep, Schrödinger, LLC, New York, 2020. Software available at https://www.schrodinger.com/products/ligprep.
   Google Scholar
• E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng, and T.E. Ferrin, UCSF Chimera—a visualization system for exploratory research and analysis, J. Comput. Chem. 25 (2004), pp. 1605–1612. doi:10.1002/jcc.20084.
   PubMed Web of Science ®Google Scholar
• Protein Preparation wizard, Schrödinger, LLC, New York, 2020. Software available at https://www.schrodinger.com/products/protein-preparation-wizard.
   Google Scholar
• Epik, Schrödinger, LLC, New York, 2020. Software available at https://www.schrodinger.com/products/epik.
   Google Scholar
• Glide, Schrödinger, LLC, New York, USA, 2020. Software available at https://www.schrodinger.com/products/glide.
   Google Scholar
• M.P. Repasky, R.B. Murphy, J.L. Banks, J.R. Greenwood, I. Tubert-Brohman, S. Bhat, and R.A. Friesner, Docking performance of the glide program as evaluated on the Astex and DUD datasets: A complete set of glide SP results and selected results for a new scoring function integrating WaterMap and glide, J. Comput. Aided Mol. Des. 26 (2012), pp. 787–799. doi:10.1007/s10822-012-9575-9.
   PubMed Web of Science ®Google Scholar
• R.A. Friesner, R.B. Murphy, M.P. Repasky, L.L. Frye, J.R. Greenwood, T.A. Halgren, P.C. Sanschagrin, and D.T. Mainz, Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein− ligand complexes, J. Med. Chem. 49 (2006), pp. 6177–6196. doi:10.1021/jm051256o.
   PubMed Web of Science ®Google Scholar
• S.S. Narang, S. Shuaib, D. Goyal, and B. Goyal, In silico-guided identification of potential inhibitors against β2m aggregation in dialysis-related amyloidosis, J. Biomol. Struct. Dyn. 38 (2020), pp. 3927–3941. doi:10.1080/07391102.2019.1668852.
   PubMed Web of Science ®Google Scholar
• J.-C. Palomino, A. Martin, M. Camacho, H. Guerra, J. Swings, and F. Portaels, Resazurin microtiter assay plate: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis, Antimicrob. Agents Chemother. 46 (2002), pp. 2720–2722. doi:10.1128/aac.46.8.2720-2722.2002.
   PubMed Web of Science ®Google Scholar
• V. Singh, R.K. Biswas, and B.N. Singh, Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds, Antimicrob. Agents Chemother. 58 (2014), pp. 1389–1396. doi:10.1128/AAC.01301-13.
   PubMed Web of Science ®Google Scholar
• A. Dagan-Wiener, I. Nissim, N.B. Abu, G. Borgonovo, A. Bassoli, and M.Y. Niv, Bitter or not? BitterPredict, a tool for predicting taste from chemical structure, Sci. Rep. 7 (2017), pp. 1–13. doi:10.1038/s41598-017-12359-7.
   PubMed Web of Science ®Google Scholar
• V. Zoete, M.A. Cuendet, A. Grosdidier, and O. Michielin, SwissParam: A fast force field generation tool for small organic molecules, J. Comput. Chem. 32 (2011), pp. 2359–2368. doi:10.1002/jcc.21816.
   PubMed Web of Science ®Google Scholar